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As many as 14-21 million people worldwide (0.3-0.5% of
the population, aged 15-65 years) use cocaine [1]. In
Europe, cocaine consumption has shown a 2- to 3-fold
increase during the last 2 decades [2,3]; in Italy, lifetime
cocaine experience among adults corresponds to 6.6%
[4]. Cocaine use and headache share some common char-
acteristics: present heavy global burden, prevail among
young individuals, cause more severe consequences in
females, may lead to emergency department access and
progress to chronification. The study of headache in
chronic cocaine users (CCU) is of interest also from a
pathophysiological point of view, given that chronic
cocaine use causes decreased dopamine and serotonin
synaptic levels, a typical migraine biochemical feature
(“empty neuron” condition) [5,6]. In a previous study we
encouraged clinicians to carry out a more in-depth inves-
tigation on cocaine use in all headache suffers, especially
those with migraine, as headache occurs in a very high
proportion of CCU (90%), mostly showing migraine or
migraine-like characteristics, while cocaine-induced
headache, as classified by the ICHD criteria [7], seems
exceedingly rare (2.2%). Moreover, we pointed out that
CCU sometimes use cocaine as an acute remedy for the
headache attack, even though improvement occurs very
rarely (17.2% of cases) [8]. Recently, it has been described
that patients with intractable cluster headache who tried
cocaine, being dissatisfied with conventional treatments
in terms of efficacy and/or tolerability, referred a full or
partial improvement in 30.8% of cases [9]. The present
study was aimed to evaluate the modification of the
clinical characteristics of headache in CCU after a 2-year
follow-up period. We contacted by phone the 80 patients
previously enrolled [8] attending the Cocaine Addiction
Service of the Drug Addiction Service, 20th District,
Rome. Of these 80 patients, 60 (still followed by the Drug
Addiction Service) were enrolled and interviewed by the
same physicians of the previous study. We studied the
modifications of headache pattern and characteristics
relative to their actual cocaine consumption in CCU
patients previously subdivided into 3 groups: neither life-
time nor current headache (group 0); lifetime and current
headache (group 1); and de novo headache, i.e. individuals
in whom headache developed only after cocaine use
began (group 2). The correlation between headache and
cocaine is controversial and still understimated.
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